DJIA 17,390.52 195.10 1.13%
NASDAQ 4,630.74 64.60 1.41%
S&P 500 2,018.05 23.40 1.17%
market minute promo

MannKind Corp (NASDAQ: MNKD)

6.01 -0.07 (-1.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $6.01 -1.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.18
Previous Close $6.08
Daily Range $5.95 - $6.24
52-Week Range $3.80 - $11.48
Market Cap $2.4B
P/E Ratio -9.21
Dividend (Yield) $0.00 (0.0%)
Volume 5,541,557
Average Daily Volume 6,093,489
Current FY EPS -$0.33

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

3 Scary Stocks to Avoid

Frightening uncertainty may mean that Dendreon, MannKind, and GW Pharma are three of the stock market's scariest stocks.

MannKind: What The Market's Implying, And Why It's Wrong.

Is Sanofi's Ouster of Viehbacher a Mistake?

Sanofi has jettisoned its long time CEO, but that might not be the best decision given challenges that lay ahead.

MannKind: What To Expect From Earnings

How MannKind Long Investors Can Profit From Short Raids

Could MannKind Corporation Be Running Out of Money?

A biotech stock running out of money is perhaps the biggest concern healthcare investors have. Find out if MannKind has the cash on hand to successfully execute on its business strategy.

Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platf

Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platform In Diabetes

Forget MannKind Corporation: 3 Better Stocks

Three Motley Fool analysts weigh in on which companies they think are better bets than MannKind.

MannKind: Massive Short Interest Could Lead To Big Gains

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

See More MNKD News...

MNKD's Top Competitors

MNKD $6.01 (-1.15%)
Current stock: MNKD
AMGN $162.18 (0.37%)
Current stock: AMGN
GILD $112.00 (-1.94%)
Current stock: GILD
BIIB $321.08 (0.02%)
Current stock: BIIB